Carole B. Cobb - Feb 2, 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Chief Operating Officer
Signature
/s/David Kennedy, Attorney-in-fact
Stock symbol
GRNA
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 06:25 PM
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Stock Option (Right to Buy) Award +428K 428K Feb 2, 2022 Common Stock 428K $0.35 Direct F1, F2
transaction GRNA Stock Option (Right to Buy) Award +43.9K 43.9K Feb 2, 2022 Common Stock 43.9K $0.35 Direct F2, F3
transaction GRNA Stock Option (Right to Buy) Award +459K 459K Feb 2, 2022 Common Stock 459K $0.33 Direct F2, F4
transaction GRNA Stock Option (Right to Buy) Award +188K 188K Feb 2, 2022 Common Stock 188K $0.33 Direct F2, F5
transaction GRNA Stock Option (Right to Buy) Award +481K 481K Feb 2, 2022 Common Stock 481K $0.50 Direct F2, F6
transaction GRNA Stock Option (Right to Buy) Award +27K 27K Feb 2, 2022 Common Stock 27K $0.50 Direct F2, F6
transaction GRNA Stock Option (Right to Buy) Award +326K 326K Feb 2, 2022 Common Stock 326K $0.98 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on July 23, 2016, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting August 23, 2016.
F2 This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
F3 20% of the shares underlying the option vested or shall vest on October 21, 2017, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting November 21, 2017.
F4 20% of the shares underlying the option vested or shall vest on September 12, 2018, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
F5 20% of the shares underlying the option vested or shall vest on May 30, 2019, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting June 30, 2019.
F6 20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting January 5, 2021.
F7 25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.